#Kidney Stone Management Devices Market growth | Explore Tumblr Posts and Blogs

shubhampawrainfinium · 1 month

Text

"Ureteroscopes: Sustainable Market Growth or Just a Passing Trend in Urology?"

Introduction

Ureteroscopes are specialized endoscopic instruments used to examine and treat conditions within the ureter and bladder. They play a crucial role in urological procedures, allowing for the minimally invasive diagnosis and management of urological disorders such as kidney stones, tumors, and strictures. The market for ureteroscopes is expanding due to advancements in endoscopic technology, increasing incidence of urological conditions, and a growing preference for minimally invasive procedures. This report provides an overview of the ureteroscope market, including market dynamics, regional trends, segmentation, competitive landscape, and future outlook.

Market Dynamics

Drivers

Increasing Incidence of Urological Conditions: The rising prevalence of urological conditions such as kidney stones, bladder tumors, and urinary tract infections drives demand for ureteroscopes. Factors contributing to this rise include aging populations, lifestyle changes, and increased incidence of chronic conditions.

Technological Advancements: Innovations in ureteroscope technology, including improved imaging capabilities, flexible designs, and enhanced maneuverability, are driving market growth. Advances in miniaturization and high-definition imaging improve diagnostic accuracy and patient outcomes.

Preference for Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures due to their benefits, including shorter recovery times, reduced postoperative pain, and lower risk of complications. Ureteroscopes enable such procedures, fueling market demand.

Challenges

High Costs: The cost of advanced ureteroscopes and associated disposable components can be high, which may limit access in cost-sensitive regions and impact adoption rates. High costs can also affect the overall affordability of urological procedures.

Technological Complexity: The advanced technology in ureteroscopes can lead to complexity in usage and maintenance. Training and expertise required to operate sophisticated devices can be a barrier to widespread adoption.

Regulatory and Reimbursement Issues: Navigating regulatory requirements and obtaining reimbursement for ureteroscopic procedures can be challenging. Variations in regulations and reimbursement policies across regions can affect market dynamics.

Opportunities

Emerging Markets: Expanding healthcare infrastructure and increasing healthcare spending in emerging markets, such as Asia-Pacific and Latin America, present significant growth opportunities for ureteroscope manufacturers.

Innovation and R&D: Continuous innovation in ureteroscope design, including improvements in flexibility, imaging, and ease of use, offers opportunities for market expansion. Companies investing in research and development can gain a competitive edge.

Growing Awareness and Training: Increasing awareness of urological health and improved training for healthcare professionals can drive demand for advanced ureteroscopic technologies. Educational initiatives and professional development programs can enhance market reach.

Sample Pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/1660

Regional Analysis

North America: The North American market is a leader due to advanced healthcare systems, high prevalence of urological conditions, and significant investment in medical technology. The U.S. and Canada are key markets with high adoption rates of innovative ureteroscopes.

Europe: Europe features a mature market with strong demand driven by well-established healthcare infrastructure and a focus on minimally invasive procedures. Major markets include Germany, France, and the UK, where there is significant emphasis on technological advancements.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth due to expanding healthcare facilities, increasing prevalence of urological conditions, and rising healthcare investments. China, India, and Japan are prominent markets with substantial growth potential.

Latin America: Latin America shows growing demand for ureteroscopes as healthcare facilities improve and investments in medical technologies increase. Brazil and Mexico are leading markets with rising adoption of advanced urological technologies.

Middle East & Africa: The market in the Middle East and Africa is developing, with increasing healthcare investments and a focus on improving urological care. The region is expected to see growth as healthcare infrastructure expands and awareness of advanced technologies increases.

Market Segmentation

By Product Type:

Rigid Ureteroscopes

Flexible Ureteroscopes

Semi-Rigid Ureteroscopes

By Application:

Diagnosis

Treatment

By End User:

Hospitals

Urology Clinics

Ambulatory Surgical Centers

By Region:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Competitive Landscape

Market Share of Large Players: Major companies such as Olympus Corporation, Karl Storz SE & Co. KG, and Boston Scientific Corporation hold significant market shares due to their extensive product portfolios and global reach.

Price Control: Large players have substantial influence over pricing due to their scale and market presence. However, competition and advancements in technology can affect pricing strategies.

Competition from Small and Mid-Size Companies: Smaller and mid-size companies challenge larger players by offering innovative or niche ureteroscopic solutions. These companies often focus on specific features or emerging technologies.

Key Players:

Olympus Corporation

Karl Storz SE & Co. KG

Boston Scientific Corporation

Stryker Corporation

Richard Wolf GmbH

Report Overview: https://www.infiniumglobalresearch.com/reports/global-ureteroscopes-market

Future Outlook

New Product Development: Continuous innovation in ureteroscope technology, such as enhanced imaging and flexible designs, is crucial for maintaining competitiveness and addressing evolving clinical needs.

Sustainability: The growing emphasis on sustainability in medical device manufacturing is shaping the market. Companies adopting eco-friendly materials and practices may appeal to environmentally conscious stakeholders and improve their market position.

Conclusion

The ureteroscope market is expanding due to increasing prevalence of urological conditions, technological advancements, and a preference for minimally invasive procedures. While challenges such as high costs and regulatory issues exist, opportunities in emerging markets and ongoing innovation offer significant growth potential. Companies focusing on new product development and sustainability will be well-positioned to succeed in this evolving market.

0 notes

healthcaremarketanalysis · 1 month

Text

Urology Devices Market worth $48.6 billion by 2028

Urology Devices Market in terms of revenue was estimated to be worth $34.1 billion in 2023 and is poised to reach $48.6 billion by 2028, growing at a CAGR of 7.3% from 2023 to 2028 according to a new report by MarketsandMarkets. The high prevalence of urological diseases significantly impacts the increased demand for urological devices. Cancer patients who need surgical interventions with latest technologies like minimally invasive surgery and robotic surgeries. This will lead to an increased need for urological devices. Thus, the escalating demand for urological disease diagnosis and treatment, has led to a pressing need for technologically advanced devices, which is thereby expected to support the growth of the urological devices market.

Download an Illustrative overview:

Browse in-depth TOC on "Urology Devices Market"

159 - Tables

44 - Figures

274 – Pages

In 2022, the instruments segment held the largest share of the urology devices market by product segment.

The urology devices market is segmented into instruments and consumables & accessories based on products. The instruments segment accounted for the largest share of the urology devices market in 2022. This segment covers the most commonly used products, such as dialysis devices, endoscopes, laser & lithotripsy devices, endovision & imaging systems, robotic systems, insufflators, endoscopy fluid management systems, urodynamic systems and other instruments. These products are commonly used in hospitals, dialysis centers and home care settings. As technologies continue to evolve, the efficiency and accuracy of these products contribute significantly to the urological procedures.

The kidney diseases segment held the largest share of the urology devices market by application segment in 2022.

The global urology devices market is differentiated into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications. In 2022, the kidney diseases segment dominated the urology devices market. The urology devices market in kidney diseases is expected to grow at a high rate owing to the rising incidence of kidney diseases and chronic diseases. With a burgeoning global population, the need for urology devices has significantly increased due to the increased number of procedures required. Hospitals and dialysis centers are at the forefront of this surge, as they cater to routine medical care and handle emergencies.

The hospitals, ASCA & clinics segment held the largest share of the urology devices market by end-user segment in 2022.

The global urology devices market is differentiated into hospitals, ASCS & clinics, dialysis centers and home care settings. In 2022, the hospitals, ASCS & clinics segment dominated the urology devices market. The urology devices market in hospitals is expected to grow at a high rate owing to the increasing number of surgical procedures related to urology care. The expanding network of healthcare institutions directly translates to a substantial market share, reflecting the pivotal role hospitals play in safeguarding patient well-being.

North America is the largest regional market for urology devices market.

The market for urology devices has been divided into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the predominant portion of the urology devices market. This can be attributed to the region's advanced healthcare facilities and substantial healthcare investments, which are pivotal in fueling the requirement for urology devices. Moreover, the projected rise in urological procedures is anticipated to contribute to the expansion of the market. As the demand for urological procedures rises, so does the need for precise urological devices to ensure successful and safe procedures.

Request Sample Pages:

Urology Devices Market Dynamics:

Drivers:

Rising incidence of urological diseases

Growing preference for minimally invasive procedures

Rising focus on R&D and product launches

Growing number of hospitals and surgical centers

Restraints:

High degree of consolidation among key players

Opportunities:

Growing Potential growth opportunities in emerging economies

Technological advancements

Challenge:

Increasing number of product recalls by key players

Shortage of skilled urologists

Key Market Players of Urology Devices Industry:

The major players operating in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland), Karl Storz (Germany), Cook Medical (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Dialife SA (Switzerland), Erbe Vision (Germany), Well Lead Medical Co., Ltd. (China), ROCAMED (Germany), EndoMed Systems GmbH (Germany), Amniso International, Inc. (US), Medispec (US), Medical Technologies of Georgia (US), Vimex Sp. z o.o. (Poland), Balton Sp. z o.o. (Poland), Hunter Urology (UK), Ribbel International Ltd. (India).

Recent Developments of Urology Devices Industry

In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.

In December 2022, Boston Scientific Corporation (US) and Acotec Scientific Holdings Limited (China) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures.

In May 2022, B. Braun SE (Germany) entered into a distribution agreement, and B. Braun surgery division Aesculap has strengthened its long-term partnership with True Digital Surgery, a Californian company that is an expert in robotically controlled 3D digital visualization.

In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)

In April 2021, Becton, Dickinson and Company (US) announced an investment of USD 65 million for the construction of a state-of-the-art medical facility in Tucson, Arizona (US), which will serve as a final stage manufacturing and sterilization center to improve overall efficiency, customer service, and supply chain in the US.

Urology Devices Market - Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Rising incidence of urological diseases, growing preference for minimally invasive procedures, rising focus on R&D and product launches, growing number of hospitals and surgical centers), restraints (high degree of consolidation among key players), opportunities (potential growth opportunities in emerging economies, technological advancements) and challenges (increasing number of product recalls by key players, shortage of skilled urologists) influencing the growth of the urology devices market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urology devices market.

Market Development: Comprehensive information about lucrative markets – the report analyses the urology devices market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.

#Global Urology Devices Market #Urology Devices Industry #Urology Devices Market Size #Urology Devices Market Growth #Urology Devices Market Outlook

0 notes

thenicheresearchusa · 2 months

Text

Exploring Key Trends in the Urological Care Market and Beyond

The healthcare industry is constantly evolving, driven by advancements in technology, growing patient needs, and the emergence of new market segments. Among the various sectors experiencing significant growth, the Urological Care Market and High Fiber Snacks Market stand out. Additionally, the role of Simulation Software in enhancing medical training and patient care is becoming increasingly crucial. In this article, we will delve into these key areas and explore the contributions of companies like The Niche Research.

Urological Care Market: A Growing Sector

The Urological Care Market is witnessing substantial growth, fueled by the rising prevalence of urological disorders such as urinary tract infections, kidney stones, and prostate cancer. With an aging population and increasing awareness about urological health, the demand for advanced diagnostic and treatment options is on the rise. This market encompasses a wide range of products, including diagnostic equipment, surgical devices, and pharmaceuticals.

The Niche Research has been at the forefront of analyzing trends and providing insights into the Urological Care Market. Their comprehensive reports highlight the latest advancements in minimally invasive surgical techniques and the development of innovative diagnostic tools. These advancements are not only improving patient outcomes but also reducing the overall cost of care, making treatments more accessible to a broader population.

The Role of Simulation Software in Healthcare

In parallel with the growth of the Urological Care Market, Simulation Software is transforming the landscape of medical education and training. This software provides a realistic, risk-free environment for healthcare professionals to practice and hone their skills. From virtual reality simulations of surgical procedures to interactive patient scenarios, Simulation Software is enhancing the proficiency and confidence of medical practitioners.

The Niche Research emphasizes the importance of Simulation Software in reducing medical errors and improving patient safety. Their studies show that regular use of simulation training can significantly enhance the technical skills and decision-making abilities of healthcare providers. This technology is particularly beneficial in urology, where complex procedures require a high level of precision and expertise.

High Fiber Snacks Market: A Rising Health Trend

As consumers become more health-conscious, the High Fiber Snacks Market is experiencing robust growth. High fiber snacks are not only beneficial for digestive health but also play a role in weight management and reducing the risk of chronic diseases such as diabetes and heart disease. This market includes a variety of products like granola bars, nuts, seeds, and whole-grain crackers.

The Niche Research has identified key trends driving the High Fiber Snacks Market, such as the increasing demand for plant-based and gluten-free options. Their reports also highlight the growing popularity of functional snacks that offer additional health benefits, like probiotics and antioxidants. With the rising trend of on-the-go snacking, high fiber products are becoming a staple in the diets of health-conscious consumers.

Conclusion

The Urological Care Market, Simulation Software, and High Fiber Snacks Market are three dynamic sectors within the broader healthcare and wellness industry. Companies like The Niche Research are playing a pivotal role in analyzing and disseminating information on these trends, helping stakeholders make informed decisions. As these markets continue to evolve, advancements in technology and changing consumer preferences will drive further growth and innovation. Whether it’s improving patient outcomes in urology, enhancing medical training, or promoting healthier eating habits, these sectors are making significant contributions to our well-being.

#Urological Care Market

0 notes

shristisahu · 6 months

Text

Ureteroscopy Devices Market: Anticipated Growth 2023-2027

Originally Published on: TechnavioUreteroscopy Devices Market by End-user, Product and Geography - Forecast and Analysis 2023-2027

The global ureteroscopy devices market is poised for significant expansion, forecasting a USD 276.91 million increase at a CAGR of 5.23% between 2022 and 2027.

Driving Forces for Market Expansion

The upswing in healthcare expenditure, particularly in emerging economies, propels advancements in healthcare infrastructure. Organizations like the World Health Organization (WHO) play a pivotal role in shaping healthcare infrastructure in emerging nations, creating favorable conditions for healthcare supply vendors. Notably, in countries such as China and India, this trend presents significant opportunities for healthcare supply manufacturers looking to expand their consumer base. The demand for ureteroscopy devices is expected to rise in developing countries, driven by their emphasis on healthcare facility advancement and large populations.

In-Depth Analysis: End-users, Products, and Geography

End-user Analysis

Hospital Segment Growth: The hospitals segment plays a crucial role in the ureteroscopy devices market. Hospitals, as primary end-users for ureteroscopy equipment, are instrumental in detecting and managing various urinary tract diseases. Due to the complexity of ureteroscopy procedures, specialized equipment requirements, and the availability of well-qualified medical personnel, these procedures are predominantly carried out in hospital settings. The hospitals segment was valued at USD 481.95 million in 2017, driven by the increasing prevalence of kidney stones and upper urinary tract diseases. Ongoing clinical trials and research on urological diseases at hospitals contribute to the rising demand for ureteroscopy devices.

Product Analysis

Flexible Ureteroscopes: Dominating the market, flexible ureteroscopes are used for studying and treating ureter-related diseases. Technological advancements, especially in single-use flexible ureteroscopes with diverse applications, contribute to the segment's high market share. Enhanced design and size improvements in flexible ureteroscopes facilitate easy access to the ureter and kidney without surgical incisions. The demand for flexible ureteroscopy devices is anticipated to increase, driven by attributes like optimized visualization, insertion tube rotation, and ergonomic design.

Semi-Rigid Ureteroscopes: Despite facing durability issues, semi-rigid ureteroscopes continue to be in demand. Companies are focusing on enhancing the durability of semi-rigid ureteroscopes, offering products with better and more robust designs. The anticipated increase in demand for semi-rigid ureteroscopy devices is supported by features like clear visualization, durable design, and autoclavable design.

Regional Analysis

North America's Contribution: Estimated to contribute 39% to the global market's growth during the forecast period, North America witnesses steady growth in the ureteroscopy devices market. Factors such as the rising prevalence of chronic kidney diseases, improved healthcare infrastructure, and the presence of global and local vendors drive market growth in North America.

Key Market Players

Companies in the market are adopting various strategies, including strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches. Key players include Advin Health Care, Advanced MedTech Holdings Pte. Ltd, B.Braun SE, Becton Dickinson and Co., Boston Scientific Corp., Coloplast AS, Cook Group Inc., ELMED Medical Systems, EMOS Technology GmbH, Erbe Elektromedizin GmbH, KARL STORZ SE and Co. KG, NeoScope Inc, Olympus Corp., Opcom Inc, ProSurg Inc., and Richard Wolf GmbH.

Market Drivers, Trends, Challenges, and Customer Landscape

Key Market Drivers

The growing prevalence of kidney stones and ureteral cancer, leading to increased demand for ureteroscopy procedures, is a key driver of market growth. The flexibility of ureteroscopy devices makes them suitable for patients who are obese, pregnant, or have blood clotting disorders.

Significant Market Trends

Technological advances in ureteroscopy devices, focusing on developing technically advanced disposable ureteroscopes, are emerging trends. Companies like Olympus and Boston Scientific offer products with enhanced imaging, deflection durability, and seamless navigation, contributing to market growth.

Major Market Challenges

The presence of substitutes for ureteroscopy devices, such as lithotripsy and percutaneous nephrolithotomy, poses a significant challenge. Patients may opt for alternative procedures, impacting the growth of the ureteroscopy devices market.

Customer Landscape

The market report includes the adoption lifecycle of the market, ranging from innovators to laggards. It analyzes adoption rates in different regions based on penetration and explores key purchase criteria and drivers of price sensitivity to assist companies in formulating effective growth strategies.

#UreteroscopyDevices #MedicalDevices #HealthcareMarket #MarketAnalysis

0 notes

mrfr-blogs · 7 months

Text

Navigating the Dynamics of Urology Devices Market Industry

Market Overview –

The Urology Devices Market encompasses medical devices and equipment used in the diagnosis, treatment, and management of urological disorders and conditions affecting the urinary tract and male reproductive system. This includes devices for urinary incontinence, kidney stones, benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), erectile dysfunction, and other urological conditions.

One significant driver of the Urology Devices Market's growth is the increasing prevalence of urological disorders worldwide, driven by factors such as aging demographics, lifestyle changes, and the rising incidence of chronic diseases such as diabetes and hypertension. As the population ages, the demand for urology devices for conditions such as urinary incontinence, BPH, and kidney stones is expected to rise.

Advancements in urological procedures and minimally invasive surgical techniques have also fueled market growth by expanding the scope of treatment options available to patients. Urology devices such as catheters, stents, lithotripters, and robotic surgical systems enable healthcare providers to perform complex procedures with greater precision, reduced recovery times, and improved patient outcomes.

Moreover, the increasing awareness of urological health and the availability of advanced diagnostic and treatment options have led to greater patient demand for urology devices and services. As healthcare systems prioritize preventive care and early intervention, the Urology Devices Market is expected to continue growing, offering opportunities for innovation and investment in medical device technology.

The Urology Devices Market is witnessing steady growth, driven by rising urological disorders and technological advancements in medical devices. Urology devices such as catheters, stents, and endoscopes are vital in diagnosing and treating urinary tract conditions. With a growing aging population and increasing awareness, the demand for urology devices continues to escalate.

The urological devices market was valued at USD 36.5 billion in 2022 and is expected to rise from USD 37.96 billion in 2023 to USD 48.5 billion by 2032, with a compound annual growth rate (CAGR) of 4% between 2023 and 2032.

Market Segmentation –

The global Urology Devices market has been segmented based on Type, Application, Technology and End-User.

On the basis of Type, the market is segmented into dialysis equipment, urinary stone treatment devices, endoscopy devices, benign prostatic hyperplasia treatment devices, and urinary incontinence & pelvic organ prolapse. The market revenue for urology devices was dominated by endoscopic devices in 2022, which can be ascribed to the rising prevalence of urolithiasis and the strong demand for disposable cystoscopes, particularly in developed nations.

Based on Application, the global Urology Devices market has been segmented into Minimally Invasive Surgery and Robotic Surgery. In 2022, the minimally invasive surgery category dominated the industry. According to projections, the terminal side segment will experience the largest growth between 2023 and 2030, with an increase in urological problem patients choosing minimally invasive procedures over more invasive ones.

Based on Technology, the global Urology Devices market has been segmented into benign prostatic hyperplasia, prostate cancer, urinary stones, and urinary incontinence. Due to the higher risk of developing urine incontinence in diabetic patients, the urinary incontinence Urology Devices category had the majority share of the market revenue for Urology Devices in 2022.

Based on End-User, the global Urology Devices market has been segmented into hospitals and ambulatory services. Due to the increasing number of patient visits at hospitals for urology-related illnesses, the hospitals and clinics segment, which held the market's top spot in 2022, is anticipated to grow at the fastest rate throughout the forecast period, 2023-2030.

Regional Analysis –

The regional analysis of the urology devices market reveals varying dynamics influenced by factors such as healthcare infrastructure development, prevalence of urological disorders, and regulatory frameworks. North America dominates the market, driven by the high prevalence of conditions like urinary incontinence and kidney stones, coupled with advanced medical technology adoption. Europe follows suit, with increasing investments in urology devices and rising demand for minimally invasive procedures. In the Asia-Pacific region, improving access to healthcare services, growing aging population, and increasing awareness about urological health contribute to market growth. Developing regions in Latin America and Africa are also witnessing gradual market expansion as healthcare infrastructure improves and awareness about urological disorders increases.

Key Players –

Urology devices companies include KARL STORZ GmbH & Co. KG, Olympus Corporation, Medtronic, Boston Scientific Corporation, R. Bard, Fresenius Medical Care AG & Co. KGaA (Germany), Dornier MedTech (Germany), and Stryker (US)

Related Reports –

US Melanoma

Middle East and Africa HIV Diagnosis & Treatment

Gastroparesis Treatment

Dental Infection Treatment

For more information visit at MarketResearchFuture

#Urology Devices Market #Urology Devices Market Size #Urology Devices Market Share #Urology Devices Market Trends #Urology Devices Market Growth

0 notes

techninja · 1 year

Text

Balancing Efficacy and Patient Experience in the Ureteral Stents Market

Introduction

The global ureteral stents market has witnessed substantial growth over the years, driven by increasing cases of urinary tract disorders and advancements in medical technology. Ureteral stents, small tubular devices placed in the ureter to ensure unobstructed urine flow from the kidneys to the bladder, have become indispensable in the field of urology. This article delves into the dynamics of the ureteral stents market, including current trends, challenges, and future growth prospects.

Market Overview

Ureteral stents are widely used in urology to manage various conditions such as kidney stones, ureteral strictures, and urinary obstruction. These devices help maintain ureteral patency, relieve pain, and prevent complications arising from urinary blockages. The global ureteral stents market has been expanding due to the rising prevalence of kidney stones, an aging population, and increased awareness about urological disorders.

Market Trends

1. Technological Advancements: Recent years have seen remarkable advancements in ureteral stent design and materials. Innovations like biodegradable stents, drug-eluting stents, and self-expanding stents are gaining traction. These technologies aim to improve patient comfort and reduce the need for frequent stent changes.

2. Minimally Invasive Procedures: A shift towards minimally invasive procedures, such as ureteroscopy and laser lithotripsy, has driven the demand for ureteral stents. These procedures reduce patient recovery times and discomfort, making stent placement a more attractive option.

3. Rising Urological Disorders: The prevalence of urological disorders, particularly kidney stones, has been on the rise globally. This has created a growing need for ureteral stents, as they are often used in the management of such conditions.

Market Challenges

1. Complications and Discomfort: While ureteral stents are essential, they are not without drawbacks. Patients often report discomfort, pain, and urinary symptoms while the stent is in place. Reducing these side effects is a challenge for the manufacturers.

2. Infection and Encrustation: Ureteral stents can become a breeding ground for infections and mineral deposits. Manufacturers are working on developing materials and coatings to mitigate these issues.

3. Cost Constraints: Ureteral stent placement can be expensive, and cost considerations may limit access to this treatment option in some regions.

Future Growth Prospects

The ureteral stents market is expected to continue its growth trajectory in the coming years. Several factors will contribute to this:

1. Aging Population: As the global population ages, the incidence of urological disorders is likely to increase, which will fuel the demand for ureteral stents.

2. Technological Advancements: Ongoing research and development in the field of urology will likely lead to more patient-friendly stent designs and materials, reducing patient discomfort.

3. Increasing Healthcare Expenditure: As healthcare expenditure continues to rise, more individuals will have access to advanced urological treatments, including ureteral stent placement.

4. Emerging Markets: Developing countries are witnessing a growing awareness of urological health and an increase in healthcare infrastructure. This will expand the ureteral stents market in these regions.

Conclusion

The ureteral stents market is poised for significant growth, driven by factors like an aging population, technological innovations, and the rising prevalence of urological disorders. While there are challenges associated with patient discomfort and complications, ongoing research and development efforts aim to address these issues. With the promise of improved patient outcomes and a more extensive market reach, the ureteral stents market will continue to be a crucial part of urological care.

Few Other Promising Reports in Medical Devices Industry

Anti-Obesity Drug Market

Angioplasty Balloons Market

Drug Eluting Balloon Market

PTA Balloon Catheter Market

0 notes

healthcaremarketfmi · 1 year

Text

Revolutionizing the Healthcare Industry: Unleashing the Potential of Stone Analysis Software Market Forecast 2023 to 2033

The stone analysis software market is poised to witness a CAGR of 3.2% during the forecast period. Over this projection period, the stone analysis software market share is estimated to reach a net worth of US$ 72.9 Million by 2032, improving from the current valuation of US$ 51.7 Million in 2022.

Kidney stone analysis test is widely adopted throughout the world because the people who had kidney stone have more chances of reoccurrence of stone. Wherever, stone analysis software plays a vital role to detect the chemical compound of kidney stones by using kidney stone analysis tools. Stone analysis software is capable of enhancing clinical results, and also improves the cost effectiveness of the treatment Stone Analysis software is based on the various algorithm such as TexRAD or other and combines image handling options with graphics interface to construct a user-friendly interface.

Stone Analysis software is systematized in modules consisting specific needs and offers personalized planning options and evaluation tools. Stone Analysis software is also adopted for training purposes as it offers intuitive workflows coupled with a manageable interface.

Stone Analysis Software Market: Drivers and Restraints

The market for Stone Analysis software is primarily driven by increasing demand for minimally invasive surgical procedures by surgeons and patients. In addition, increasing prevalence and incidence of nephrolithiasis also boost the growth of stone analysis software market. For instance, according to the research conducted, Stone disease is common with the lifetime risk of stone formation in the US exceeding 12% in men and 6% in women, and approximately millions of people affected by the stone disease on a global level. However, low awareness among patient in emerging countries, the high cost of software and lack of highly skilled professional are the major obstacles in driving the market growth of stone analysis software.

Stone Analysis Software Market: Overview

Stone Analysis software is widely adopted due to increasing prevalence of urolithiasis, especially high rate of kidney stone reoccurrence technological development in minimally invasive procedure and improvement in kidney stone management devices further increase the demand of stone analysis software which is expected to boost the growth of stone analysis software market.

Furthermore, according to National health and nutrition examination survey: annually three in 20 men and two in 20 women have prevalence of kidney stones globally. In 2012, the prevalence of kidney stones in men was 10.6% and was 7.1% in women .Companies involved in strategic collaboration, merger/acquisition and increasing investments in research and development to make cost-effective product portfolio. Stone analysis software market has high growth potential which is likely to attract new companies over the forecast period

For More Information: https://www.futuremarketinsights.com/reports/stone-analysis-software-market

Stone Analysis Software Market: Region-wise Outlook

In terms of geography, Stone Analysis software market has been divided into seven regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding Japan, Japan Middle-East & Africa, and Latin America. The market in North America for Stone Analysis software is expected to remain the dominating region owing to the developed and improved healthcare facilities in these regions. In addition, increasing demand for minimally invasive surgical procedures and higher awareness is also impelling the growth of Stone Analysis software market.

The stone analysis software market in the Asia Pacific excluding Japan is expected to emerge as a fastest growing region owing to the large percentage of diseased population in these regions (China and India). The stone analysis software market in Latin America is also anticipated to show a positive growth over the forecast period owing to the improving healthcare infrastructure and increasing trend of medical tourism in countries such as Brazil, and Argentina. The region such as the Middle East & Africa is anticipated to show a steady growth of stone analysis software over the forecast period.

Stone Analysis Software Market: Key Market Participants

Some of the Stone Analysis software participants are Stone Profit Systems, Stone Checker, and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

0 notes

pranalipawarshinde · 2 years

Text

Minimally Invasive Surgery Market to advance at a CAGR of 3.2% from 2022 to 2031

Minimally Invasive Surgery Market Outlook 2031

The global minimally invasive surgery market was valued at US$ 231.1 Bn in 2021

The global market is projected to advance at a CAGR of 3.2% from 2022 to 2031

The global minimally invasive surgery market is anticipated to cross US$ 324.9 Bn by the end of 2031

Request A Free Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=66893

Overview of Global Minimally Invasive Surgery Market

Minimally invasive procedures enable a surgeon to use techniques that limit the size and number of cuts, or incisions, that need to be made. Advancements in minimally invasive surgery devices have revolutionized these procedures. Using minimally invasive technology has improved patient outcomes and recovery all over the world. Minimally invasive and robotic procedures allow the surgeons to advance in video imaging by virtue of voice control over the networked operating room.

Robotic procedures represent the latest development in minimally invasive procedures, providing surgeons with precision devices that employ the same small incisions as conventional laparoscopy. A key difference is that the robotic system can offer broader visualization of the operative field and precision control of minimally invasive surgery devices.

Read Report Overview: https://www.transparencymarketresearch.com/mis-market.html

AI-enabled services, 3D printing, and new imaging methods are increasingly being utilized in surgery. These are some of the key factors that are boosting the minimally invasive surgery market.

Faster Recovery and Shorter Hospital Stay Propelling Demand for Minimally Invasive Surgeries

Less wound pain, faster functional recovery, and shorter hospital stay are the key advantages of minimally invasive surgery (MIS) over open surgery. Minimally invasive procedures are also linked to significantly less blood loss, lower analgesic consumption, a faster time to first flatus and a soft diet, and a shorter postoperative hospital stay as compared to open surgery. Awareness about the benefits of minimally invasive surgeries is increasing among patients. This is compelling healthcare companies to increase the manufacturing of minimally invasive surgery equipment.

According to Transparency Market Research (TMR) Healthcare Research findings, based on our pilot population study, we observed that most patients with renal calculi, prefer endoscopic procedures to manage the removal of kidney stones. They prefer a minimally invasive procedure instead of open surgery, owing to the high degree of awareness. Demand analysis of minimally invasive surgery suggests that endoscope technology and instrumentation have made it possible to convert many procedures in many surgical specialties from open surgeries to endoscopic ones.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=66893

Surgical Robots Performing Complex Procedures Likely to Boost Market Growth

Robotic surgery is a modern technique that offers significant results in various types of surgical procedures. A rapid increase in the adoption of robotic surgery for minimally invasive procedures is attributed to a blend of technological improvements such as the use of more efficient motors, compact & light materials, power backup, sophisticated controls, and safety mechanisms, along with more cost-effective versions. The high precision of robot-assisted surgery helps in accurate implant positioning and reduces the risk of injury to adjacent tissues. Patients also benefit from less bleeding and post-operative pain, and fewer hospital readmissions.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=66893

Growth prospects for minimally invasive surgery market lie in innovations in surgical robotic systems. Robots are also becoming increasingly important in the field of minimally invasive surgery due to the growing complexity of procedures in order to treat difficult diseases. In 2020, more than 900,000 procedures were performed in the U.S., and about 5,000 robotic platforms were equipped in hospitals across the country.

According to a key opinion of Cleveland Clinic, on an average, around 35% of all colorectal surgery in the Atlanta area of the U.S. is being performed robotically for the last 2 to 3 years.

Increasing Adoption of Laparoscopic Surgery Creating Revenue Opportunities for Stakeholders

In terms of procedure, the global minimally invasive surgery market has been classified into laparoscopic surgery, robotic surgery, endoscopic mucosal resection, endoscopic submucosal dissection, and transcatheter.

The laparoscopic surgery segment led the market in 2020, and the trend is expected to continue during the forecast period due to the high rate of adoption of laparoscopy procedures to help diagnose different medical conditions that arise within the abdomen or pelvis.

Additionally, advanced laparoscopy devices are used to perform surgical procedures such as the removal of a diseased or damaged organ or a tissue sample for further testing (biopsy). Substantially low maintenance costs of laparoscopic handheld minimally invasive surgery devices and a rise in technological innovations in handheld instruments are likely to augment the laparoscopic surgery segment during the forecast period.

The market value of the minimally invasive surgery market is expected to grow since the transcatheter segment is likely to expand at a high CAGR from 2022 to 2031 due to a rise in transcatheter aortic valve implantation procedures. Demand for this procedure is predicted to increase exponentially owing to an aging population worldwide.

High Prevalence of Orthopedic Disorders Driving Minimally Invasive Surgery Market

The orthopedic segment held a significant share of the global market, in terms of revenue, in 2020. The trend is likely to continue during the forecast period since this segment is one of the fastest growing market for minimally invasive surgery.

An estimated 22 million orthopedic procedures were performed worldwide in 2017, and this number is only expected to grow. Therefore, a high number of cases of orthopedic disorders, such as the fracture of bones, bone cancer, etc., propels the demand for minimally invasive surgery across the globe.

Favorable Reimbursement Policies Increasing Hospitals Visits of Patients, Contributing to Market Growth

In terms of end-user, the global minimally invasive surgery market has been divided into hospitals, clinics, ambulatory surgical centers, and others.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=66893

A rise in the number of operating rooms in developing countries in hospitals, an increase in the number of patient’s preference to visit hospitals due to medical reimbursement, availability of advanced minimally invasive surgery devices, and the surgeons’ capabilities to perform different types of minimally invasive surgery are expected to drive the segment during the forecast period. As of February 2019, there were a total of 33,000 hospitals in China, an increase of 1,866 in the same period of 2018.

Regional Outlook of Global Minimally Invasive Surgery Market

In terms of region, the global minimally invasive surgery market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.

Europe accounted for a prominent share of the global minimally invasive surgery market in 2020. The trend is projected to continue during the forecast period due to an increase in the geriatric population in the region. According to the Eurostat, in 2017, around 19%, or one-fifth, of the European Union (EU) population was aged 65 and above.

The minimally invasive surgery market in Latin America is anticipated to grow at a prominent CAGR from 2022 to 2031. This is attributed to an increase in the popularity of minimally invasive procedures over traditional surgeries, a surge in the incidence of lifestyle-related and chronic illnesses, and technical developments in countries in Latin America.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=66893

Competitive Landscape of Global Minimally Invasive Surgery Market

The global minimally invasive surgery market is fragmented due to the presence of a large number of players. Key players operating in the global market include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Johnson & Johnson Services, Inc., Medtronic plc, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet.

Key hospitals that have been also profiled in the report include Apollo Hospitals Enterprise Limited, Huntington Hospital, Johns Hopkins Hospital, Massachusetts General Hospital, Rutland Medical Center, Saint Michael's Hospital, Singapore General Hospital, The Ottawa Hospital, and University of Pittsburgh Medical Center Washington Hospital Healthcare System.

Key players are adopting growth strategies such as new product development, product launches, product approval, agreement, partnerships, and mergers.

Each of these players has been profiled in the minimally invasive surgery market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

More Trending Reports by Transparency Market Research:

Digital Dentistry Materials & Systems Market: https://www.transparencymarketresearch.com/digital-dentistry-materials-and-systems-market.html

Dry Eye Disease Diagnostic Devices Market: https://www.transparencymarketresearch.com/us-dry-eye-disease-diagnostic-devices-market.html

Elderly and Disabled Assistive Devices Market: https://www.transparencymarketresearch.com/elderly-disabled-assistive-devices.html

Meningitis Diagnostic Testing Market: https://www.transparencymarketresearch.com/emea-meningitis-diagnostic-testing-market.html

Heart Lung Machine Market: https://www.transparencymarketresearch.com/heart-lung-machine-market.html

ASEAN Biological Optical Microscope Market: https://www.transparencymarketresearch.com/asean-biological-optical-microscope-market.html

Gastrointestinal Testing Panels Market: https://www.transparencymarketresearch.com/emea-gastrointestinal-testing-panels-market.html

Assistive Technologies for Visually Impaired Market: https://www.transparencymarketresearch.com/assistive-technologies-visually-impaired-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email: [email protected]

0 notes

paullui2002 · 2 years

Text

Kidney Stone Retrieval Devices Market Share, Sales Channels and Overview Till 2027

Kidney stone retrieval devices are tools or equipment that assist in treating kidney stones. The kidney stone devices include a wide range of stone retrieval tools such as lithotripter, stone baskets, ureteral stents, ureterorenoscopes, guidewires, and access sheath. These tools are similar to the tube-like structure that attach with a camera that visualizes the position of stones inside the ureter, and tools such as lithotripter are used to break down stones into pieces, and stone basket helps in holding the stones pieces collectively. Accessories such as guidewires and access sheaths help in inserting stone removal devices into the ureter.

According to our new market research study on “Kidney Stone Retrieval Devices Market to 2027 – Global Analysis and Forecast – by Type, Treatment, End User,” the market is expected to reach US$ 3,653.92 million by 2027 from US$ 2,541.07 million in 2019; it is estimated to grow at a CAGR of 4.8% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Get Sample PDF Here @ https://www.theinsightpartners.com/sample/TIPRE00010715/

Technological developments in medical devices have led to various options for the treatment of renal and urological diseases. The implementation of robotics in surgeries for treating urolithiasis has gained popularity in the recent years. Currently, the Vinci Surgical System, provided by Intuitive Surgical Inc., is a widely used robotic system in surgeries performed for treating urolithiasis. Similarly, at present, technological developments have enabled various surgical procedures such as ureterorenoscopy (URS), PCNL, SWL is laparoscopy, and robot-assisted interventions have made significant evolution in kidney stone management and retrieval procedures. Since the past 20 years, the adoption of endourological interventions for the treatment of kidney stones has increased significantly across various North American, European, and Asian countries. On the back of such technological developments, the scope of robotic surgeries is likely to be extended to the treatment of kidney or ureteric stones in the coming future.

Market leaders operating in the market have undertaken various organic and inorganic growth strategies in the kidney stone retrieval devices market. The kidney stone retrieval devices market majorly consists of the players such as COLOPLGAST CORP, Boston Scientific Corporation, BD, Cook Medical, Olympus Corporation, Storz Medical AG, Lumenis, Walz Elektronik GmbH, Dornier Medtech GmbH, and Richard Wolf GmbH, among others.

Several in organic approaches, such as product launches, and expansion in the kidney stone retrieval devices market, have resulted in the positive growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have help the company to strengthen its revenue, which allows the company to hold a strong position in the market.

Read Complete Report Here @ https://www.theinsightpartners.com/reports/kidney-stone-retrieval-devices-market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: [email protected]

Phone: +1–646–491–9876

#Kidney Stone Retrieval Devices Market #Kidney Stone Retrieval Devices #Kidney Stone Retrieval Devices Industry

0 notes

healthcaremarketanalysis · 2 months

Text

Urology Devices Market worth $48.6 billion by 2028

Urology Devices Market Trends

Download an Illustrative overview:

Browse in-depth TOC on "Urology Devices Industry"

159 - Tables

44 - Figures

274 – Pages

In 2022, the instruments segment held the largest share of the urology devices market by product segment.

The kidney diseases segment held the largest share of the urology devices industry by application segment in 2022.

The hospitals, ASCA & clinics segment held the largest share of the urology devices industry by end-user segment in 2022.

North America is the largest regional market for urology devices industry.

Request Sample Pages:

Urology Devices Market Dynamics:

Drivers:

Rising incidence of urological diseases

Growing preference for minimally invasive procedures

Rising focus on R&D and product launches

Growing number of hospitals and surgical centers

Restraints:

High degree of consolidation among key players

Opportunities:

Growing Potential growth opportunities in emerging economies

Technological advancements

Challenge:

Increasing number of product recalls by key players

Shortage of skilled urologists

Key Market Players of Urology Devices Industry:

Fresenius Medical Care AG & Co. KGaA (Germany) maintained its dominant position in the urology devices market in 2022. The company’s strong distribution networks spanning North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa have contributed to its sustained leadership in the market. The company employs organic and inorganic growth strategies to enhance its market dominance, such as product launches, approvals, mergers, collaboration and expansion. In April 2021, the company opened a new technology center in Schweinfurt for developing dialysis machines. In line with this, in November 2021, Fresenius launched new device CorAL which is a dialyzer for hemodialysis. In April 2020, Fresenius Medical Care North America collaborated with DaVita Inc. and other dialysis providers in response to COVID-19, which aimed to support the broader kidney care community in the United States. These strategic initiatives enable Fresenius Medical Care to secure a larger market share and strengthen its position in the urology devices market.

In 2022, Baxter International, Inc. (US) held a significant market share in the urology devices market. The company’s leading position can be attributed to its robust global sales and distribution network in around 100 countries, which effectively promotes its products across various countries. Baxter International has strategically emphasized research & development (R&D) initiatives to develop innovative and superior offerings compared to its competitors. By investing in R&D, the company aims to optimize its product portfolio and allocate capital wisely, thereby fostering future growth and maintaining its competitiveness.

Furthermore, Baxter International implements both organic strategies, such as regulatory approvals and product launches, to further strengthen its standing in the urology devices market. In November 2022, the company launched a hemodialysis device named HDx Therapy. This strategic move expanded the company’s product line considerably and enhanced its market visibility, bolstering its overall position in the industry. In April 2022, Baxter received U.S. FDA Clearance of ST Set used for renal replacement therapy.

Boston Scientific Corporation (US), a prominent player in the global urology devices market, secured a significant market share in the urology devices market in 2022. The company’s strong presence in North America, Europe, Asia Pacific, Middle East & Africa strengthens its geographical reach. Boston Scientific Corporation caters to a diverse customer base across various geographic locations. In addition to its R&D efforts and supply chain management, Boston Scientific leverages inorganic growth strategies to maintain its market leadership. For example, in December 2022, Boston Scientific acquired 65% stakes in Acotec Scientific Holdings Limited. Such developments contribute to the company’s continued success and its sustained leading position in the urology devices market.

Recent Developments of Urology Devices Industry

In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.

In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)

Get 10% Free Customization on this Report:

Urology Devices Market Recent Developments:

In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.

In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)

Urology Devices Market - Key Benefits of Buying the Report:

The report provides insights on the following pointers:

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urology devices market.

Market Development: Comprehensive information about lucrative markets – the report analyses the urology devices market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market

#Global Urology Devices Market #Urology Devices Industry #Urology Devices Market Size #Urology Devices Market Growth #Urology Devices Market Outlook

0 notes

jesse-pinkman123 · 2 years

Link

The Kidney Stone Management Devices Market research report is an intelligence report that includes precise and valuable data on market size, development countries, market share, and revenue forecasts through 2028. It also provides information on the market’s development and capabilities.

#Kidney Stone Management Devices Market Outlook #Kidney Stone Management Devices Market Growth

0 notes

medicaldevicetech · 5 years

Text

Kidney Stone Management Devices Market Survey: Size, Share, Trends and Demand

Kidney Stones Management Market Synopsis:

The changes in lifestyle have led to a drastic increase in the patient population of urolithiasis. This, in turn, has led to rapid developments in technology and diagnosis. Market Research Future (MRFR) has asserted in its latest study that the global kidney stone market is expected to expand at a moderate 4.6% CAGR and reach USD 2,508.01 Million till 2025. Technological innovations are poised to dictate the growth trajectory of the market in the years to come.

The introduction of minimally invasive procedures has revolutionized the growth pattern of the healthcare sector. A similar trend is likely to positively influence the expansion of the kidney stone management devices market over the next couple of years. The advancements in the diagnosis of kidney stones through minimally invasive procedures is expected to boost the revenue generation of the market across the review periodzz.

The large-scale prevalence of the chronic disease, diabetes, is anticipated to affect a larger fraction of the population in the foreseeable future. Thus, the kidney stone market is projected to remain highly lucrative over the next few years. However, the adverse effects of extracorporeal shock wave lithotripsy can pose a challenge to the market players.

Market Segmentation:

By type, the global Kidney stones management market has been segmented into uric acid, calcium stones, struvite kidney stones, and cystine stones. Among these, the calcium stones segment has gained higher traction of the market and is anticipated to retain its dominance over the next few years.

On the basis of treatment, the kidney stone market has been segmented into medications, ureteroscopy (URS), extracorporeal shock wave lithotripsy (ESWL), and percutaneous nephrolithotomy (PCNL). The ureteroscopy (URS) segment is likely to generate relatively higher revenue as it is preferred by the patients over other methods.

The global kidney stone market, by diagnosis, has been segmented into intravenous pyelography (IVP) or intravenous urogram, ultrasound, CT scan, and X-ray. Among these, the ultrasound segment is anticipated to hold the pole position in the market and grow substantially over the assessment period. The process doesn’t use radiation which is anticipated to support the growth pattern of the segment.

Regional Analysis:

By region, the global kidney stone market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa (MEA). North America is currently leading the growth of the global market. It is anticipated to retain its prominence over the assessment period. Europe is at the second spot and is likely to grow leaps and bounds during the review period. On the other hand, Asia Pacific is projected to exhibit significant growth owing to the presence of fast-developing economies such as India, China, etc.

Competitive Dashboard:

The prominent players operating in the global kidney stone market are EDirexGroup (Israel), Boston Scientific Corp. (U.S.), .M.S. Electro Medical Systems S.A. (Switzerland), Elmed Electronics & Medical Industry & Trade Inc. (Turkey), Convergent Laser Technologies (U.S.), Medispec Ltd. (U.S.), C.R. Bard Inc. (U.S.), Dornier MedTech GmbH (Germany), Cook Medical Inc. (U.S.), Richard Wolf GmbH (Germany), Stryker Corp. (U.S.), STORZ MEDICAL AG (Switzerland), Siemens Ltd. (Germany), and Olympus Corp. (Japan).

Industry News:

In April 2019, Dornier MedTech (Dornier), a leader in kidney stone management, announced the launch of AXIS™ Single-Use Digital Flexible Ureteroscope (AXIS™) along with Stone Management Products for the U.S. market.

In December 2018, Shockwave Medical, a pioneer in urologic lithotripsy for breaking up kidney stones, has collaborated with Abiomed Inc., a medical device company, for the complementary use of their respective technologies.

In July 2018, a global leader in innovative kidney stone management, Dornier MedTech (Dornier), has introduced a new laser portfolio for the Singapore market which comprises of Dornier Medilas H 140 and Dornier Medilas H Solvo 35 for urological stones.

Read More @ https://www.marketresearchfuture.com/reports/kidney-stones-market-1745

#Kidney Stone Management Devices Market #Kidney Stone Management Devices Market size #Kidney Stone Management Devices Market share #Kidney Stone Management Devices Market growth

0 notes

researchinhealthcare · 3 years

Text

Hematuria Treatment Market 2021-2027 High Key Players For Market, Application, Product Sort, Statement

Hematuria Treatment Market Overview :

The hematuria treatment market is accruing rapidly mainly due to the increasing number of bladder or kidney stones; kidney disease; urinary tract infection, cystitis (bladder infection), or pyelonephritis (kidney infection); cancers of the urinary tract (kidney, bladder, prostate); trauma, injury, or urinary tract instrumentation; rigorous exercise; benign prostatic hyperplasia; and blood thinners for such as Antithrombotic medications.

In addition to the chronic diseases, infection or diseases are too impacting the market growth positively. At the same time, there are various treatments and novel medications available for hematuria management which are pushing up the market on the global platform.

Acknowledging the colossal growth, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global hematuria treatment market will grow exponentially by 2023 accruing at a striking CAGR during the forecast period (2018 – 2023).

Furthermore, technological advancements transpired in the field of hematuria management and advent treatment materials are fostering the market growth of hematuria treatment to an extent.

On the other hand, factors such as the complications in the treatment, high cost of product developments, and stringent regulations for approvals are expected to obstruct the market growth during the assessment period. Also, the pending or imminent patent expiries of many blockbuster hematuria management drugs are some hampering the market growth.

Nevertheless, factors like the instigation of a large number of regulatory healthcare reforms, developments of methods for the improved diagnosis and treatments for hematuria are expected to support the market growth bringing about the hematuria management therapeutics and treading along a promising increase in the next few years.

Hematuria Treatment Market – Segments :

The MRFR analysis is segmented into five key dynamics for the convenience of understanding;

By Type : Gross/ Macroscopic Hematuria, Microscopic Hematuria, Idiopathic Hematuria, and Jogger’s Hematuria.

By Causes : Kidney Stones, Urinary Tract Infections (UTI), Urethritis, Blood Cancer, Bladder Stones, Prostate Cancer, Cystitis, Trauma, Vigorous Exercise, Polycystic Kidney Disease, Endometriosis, and Menstruation.

By Treatment : Drugs and Therapeutics, among others.

By End-user : Hospitals, Clinics, and Labs among others.

By Regions : North America, Europe, APAC, and the Rest-of-the-World.

Get Free Sample of This Report at : https://www.marketresearchfuture.com/sample_request/1732

Hematuria Treatment Market – Regional Analysis :

The North American region dominates the global hematuria treatments market. The growing prevalence of kidney diseases, bladder cancer, and others along with the high per capita healthcare expenses drive the growth in the regional market.

Some of the factors such as the increasing technological innovations in medical science and the growing investments into R&D to develop new techniques to treat hematuria are substantiating market growth.

Besides the high consumption of antibiotics in the treatment of various chronic diseases, the presence of a well-established healthcare system, and rising cases of trauma & accidents foster the growth of the hematuria management market in the region.

Europe hematuria treatment market stands at the second position in terms of the size. The market in this region exhibits a phenomenal growth prospect throughout the review period.

Furthermore, factors like financial support from the government for R&D activities, and the increasing demand for hematuria treatments & devices drive the market growth in the region. Besides, the rising incidences of accidental injuries are contributing to the market growth in this region, generating a massive demand for the management of hematuria.

The Asia Pacific hematuria treatment market is emerging as a profitable market. Factors such as the increasing healthcare expenditure and increasing prevalence of hematuria led by the growing incidences of infections related to the urinary tract, bladder, and kidney drive the growth of the hematuria treatment market in the region.

The increasing governmental funding alongside a large unmet needs presages towards the growth opportunities for the market players. Spreading awareness about the availability of different hematuria management procedures is accelerating the market growth in the region. Besides, the availability of low-cost, quality hematuria management methods drives the regional market.

Hematuria Treatment Market – Competitive Analysis :

The highly competitive hematuria treatment market appears fragmented owing to a number of players and the increasing investments made by them in R&D activities in the hematuria management. Through the strategic partnership, acquisition, expansion, product & technology launch, and collaboration, these players try to gain a competitive edge.

Hematuria Treatment Market Key Players :

Some of the leaders of the market include Bristol-Myers Squibb, AstraZeneca Plc., F. Hoffmann-La Roche Ltd., Janssen Pharmaceuticals, Inc., GlaxoSmithKline Inc., Merck & Co., Sun Pharmaceutical Industries Limited, Novartis International AG, Pfizer, Inc., and The Medicines Company among others.

Industry/Innovation/Related News :

January 22, 2018 – Researchers at the Sunnybrook Health Sciences Centre’s Division of Urology (Canada) published the result of their study to investigate or manage hematuria in the Journal of the American Medical Association. Researchers examined the rate of hematuria-related complications in over 800,000 elderly patients. And, found that Antithrombotic medications, commonly known as blood thinners are associated with significant adverse events such as blood in the urine (hematuria) or the bleeding within the skull and stomach/ intestines as these drugs allow blood to flow easier throughout the cardiovascular system.

Browse Full Report with TOC at : https://www.marketresearchfuture.com/reports/hematuria-treatment-market-1732

#HematuriaTreatmentresearchreports #HematuriaTreatmentmarketsize #HematuriaTreatmentindustryanalysis #HematuriaTreatmentmarketanalysis #HematuriaTreatmentmarketresearch #HematuriaTreatmentmarket

1 note · View note

optimainsights-post · 5 years

Text

Urinary Stones Treatment Devices Market to Grow at 4.4% CAGR to Reach US$1.98 billion by 2026

The Global Urinary Stones Treatment Devices Market was valued at US$1.48 billion in the year 2018 and is expected to reach US$1.98 billion by 2026, at a CAGR of 4.4%.

Urinary stones are mainly formed due to the inability of an individual to empty the urinary bladder. Due to urine accumulation, the minerals in the concentrated urine start crystalizing leading to the formation of stones. Depending on the location of the stone development it may be classified as a kidney stone, bladder stone or ureteral stone. These stones are diagnosed using, abdominal X-ray, CT scan, MRI scan, ultrasound, etc. During the early days, the stones were removed through surgical procedures. But the development of technologies such as lithotripsy, ureteroscopy, nephrolithotomy had reduced the hurdles in treatment and the removal of urinary stones. Also growing popularity of digital flexible ureteroscopes and rising focus on the development of lasers alternative to conventional once are the factors that contribute to the market growth.

Urolithiasis and Nephrolithiasis are the main conditions that contribute to the development of kidney stones in individuals and chiefly contribute to market growth. Besides, the recurrence of kidney stones in the adult population has also risen to 50% in recent decades due to enormous changes in the lifestyle, poor dietary habits, an increase in obesity, less intake of water and many other associated morbidities. Moreover, as recent research suggested, the probability of recurrence of nephrolithiasis in adolescents or children is about 50% within 3 years of the first occurrence. According to the National Kidney Foundation, over half a million people across the globe visit emergency rooms every year. International Federation of Kidney Foundations and the International Society of Nephrology are taking several initiatives to create awareness among the people regarding the equitable and inexpensive access to treatment options, screening, and diagnosis. This is set to drive the Urinary Treatment Devices market during the forecast period.

Implementation of imaging technologies for scanning urinary stones is expected to drive the growth in the upcoming years. Among diagnoses, the ultrasound segment emphasizes reducing the amount of ionizing radiation delivered to patients during routine imaging. It has also become a mainstay tool in the urologists' armamentarium for the diagnosis and management of nephrolithiasis. New advancements in ultrasound technology had also facilitated its use as a therapeutic and therapy guidance aid. Ultrasound is being used as the first line for the diagnosis of urinary stones for more than 14 years and is set to grow with a healthy CAGR of 5.1% during the forecast period. Other diagnostic techniques such as MRI, intravenous pyelogram, non-contrast CT are said to contribute very little when compared to ultrasound.

Adoption of an alternative way of treatment such as Chinese herbal medicine, Ayurveda, acupressure was minimal during the yesteryears. However, after the rediscovery of the ancient techniques, the options for treating urinary stones with herbal medicine, acupressure, etc. are being researched more and few options have also become successful in minimizing the urinary stones. This is set to hamper the market growth as WHO had already initiated a global level initiative to study and standardize the usage of medicinal plants including that of the folklore medicine.

However modern medicine offers an effective way of treatment. Among them, the lithotripsy segment has a huge demand in the market treating urinary stones and also to sidestep the invasive surgical procedures that were used for stone removal. Lithotripsy uses ultrasonic energy or shock waves focused directly on the stone to identify the place which was previously located with fluoroscopy or ultrasound of the stones. The patient is positioned in such a way so that the stones are targeted precisely. By using this lithotripsy, the complications, hospital stays, costs and recovery time are reduced. The treatment using lithotripsy is expected to fuel market growth until 2026.

Among stone types, the calcium oxalate segment has been reported to propel the urinary stones market till 2018. The formation of calcium oxalate stones is strongly linked to the consumption of foods consisting high amount of oxalate that naturally occurs in plants and animals. This includes beets, black tea, chocolate, nuts, potatoes, and spinach. Also, calcium in the form of supplements for several other bone-related disorders may increase the chances of forming new calcium oxalate stones in the urine. Also, consumption of more leguminous foods such as dried beans, peas, anchovies and drinking of beer may increase the chances of uric acid crystal formation due to the deposition of purines in the kidney.

North American region highly dominates the urinary stones treatment devices market due to extensive prevalence in the occurrence of urinary stones. The favorable conditions for research and development, increased healthcare expenditure and growing utilization of advanced technology for the treatment aspects are evident in this region. The US market holds a market share of about 65% to 35% whereas the Canadian market share is set to increase by around 2% during the forthcoming years due to more immigration from other countries. Further, government initiatives towards strengthening the healthcare infrastructure are accelerating the growth of the urinary stone treatment devices market in this region. Followed by the North American region is the European region, where Germany alone contributes to more than 27% of the total European market growth due to more occurrence of Urolithiasis among German individuals followed by France, the UK, Italy, and Spain. Besides, the Asia Pacific and the Middle East countries are also expected to contribute to the market growth having potential opportunities falling under the kidney stone belt of the world.

Some of the key players in the urinary stones treatment devices market are, Becton, Dickinson and Company, Boston Scientific Corporation, EDAP TMS S.A., Olympus Corporation, Coloplast A/S, Siemens Healthineers, Convergent Laser Technologies, Cook Medical Inc, Direx Group, Dornier MedTech GmbH, Elmed Electronics & Medical Industry & Trade Inc, KARL STORZ GmbH & Co. KG, Lumenis Ltd, Medispec LTD, Richard Wolf Medical Instruments Corporation, Allengers Medical Systems Ltd and E.M.S. Electro Medical Systems SA.

Request for Sample Pages @ https://www.optimainsights.org/sample-request/145-urinary-stones-treatment-devices-market

Key Updates:

FDA Approves Retrophin’s New Formula Thiola EC (tiopronin) for treating Cystine Kidney Stones

Dornier’s new Gemini stone-busting system: The pulverizer is both a step into the future and a blast from the past

Dornier launches AXIS™ Single-Use Digital Ureteroscope for treating Urinary Stones

Journal Summaries in Internal Medicine: Researchers examined the utility of experimental Thulium fiber laser (TFL) as an alternative to the gold standard Holmium: YAG laser for lithotripsy

The Report Provides Key Insights on

History of the Urinary Stones Treatment Devices Market, 2015 to 2017

Forecast of the Urinary Stones Treatment Devices Market Growth till the year 2026

The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Urinary Stones Treatment Devices Market

Analysis of potential growth segments which will drive the market

Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market

Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics

Urinary Stones Treatment Devices Market Based on Diagnosis (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

· Abdominal X-Ray

· Computed Tomography(CT) Scan

· Intravenous Pyelography (IVP)

· Ultrasound

· Abdominal MRI

Urinary Stones Treatment Devices Market Based on Treatment (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

· Percutaneous Nephrolithotomy (PCNL)

· Ureteroscopy (URS)

· Extracorporeal Shock Wave Lithotripsy (ESWL)

Urinary Stones Treatment Devices Market Based on Stone Type (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

· Calcium Phosphate

· Cystine

· Struvite

· Uric Acid

· Calcium Oxalate

Urinary Stones Treatment Devices Market Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

· North America

· Europe

· APAC

· LAMEA

Urinary Stones Treatment Devices Market Competitive Analysis (Company Overview, SWOT Matrix, Financial, Product Overview, and Market Strategies)

· Siemens Healthineers

· Direx Systems Corp

· Dornier Medtech Gmbh

· Elmed Electronics & Medical Industry & Trade Inc

· Karl Storz Gmbh & Co. KG

· Lumenis Ltd

· Medispec Ltd

· E.M.S. Electro Medical Systems SA

Download Complete TOC of the Report @ https://www.optimainsights.org/request-toc/145-urinary-stones-treatment-devices-market

About Us

Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.

Contact

Optima Insights

Mr. Chucks G

+91 966 6620 365 (Asia) | +1 424 2554 365 (US)

Email: [email protected]

https://www.optimainsights.org

#Urinary stones treatment devices market #Urinary Stones Treatment Devices Market Analysis #Urinary Stones Treatment Devices Market Forecast

0 notes

coldpenguintaco · 5 years

Text

Kidney Stone Management Devices Market Predicted to Witness Highest Revenues by 2028

Global sales of kidney stone management devices are likely to surpass 1 million units by 2028, according to a new Fact.MR study. In terms of revenues, the study projects the kidney stone management devices market to surpass US$ 1,500 million.

Rising preferences for minimally-invasive and non-invasive surgical procedures continues to be a massive trend in the kidney stone management devices market

View On WordPress

#Kidney Stone Management #Kidney Stone Management Devices #Kidney Stone Management Devices Market #Kidney Stone Management Devices Market Growth #Kidney Stone Management Devices Market Sales

0 notes

meditech-insights · 2 years

Text

Continence Care Market Overview by Increasing Demands and Sales 2021 – 2026

Continence is the skill to voluntarily control emptying the bladder and bowels effectively in a hygienic way while ‘Incontinence’ is the unwanted and involuntary leakage of urine or stool. Incontinence is estimated to affect approximately 400 million people worldwide.

Continence issues can arise due to spinal cord injuries, birth defects, multiple sclerosis, or aging-related disorders including benign prostatic hyperplasia (BPH). To address these concerns, continence care products are broadly used across medical facilities and they form an integral part of hospital & continued care in home settings for patients. It contains products such as intermittent catheters, external/foley catheters, urine bags, and products for bowel management (colostomy bags, nerve modulation devices, irrigation systems & other accessories).

The Global Continence Care Market valued at US$ 2.8 bn (2021) is expected to witness a growth rate of 5% in the next five years. The rising geriatric population, increasing cases of spinal cord injuries, prostate enlargement, prostatectomy, spina bifida, multiple sclerosis, urinary incontinence, benign prostatic hyperplasia (BPH), kidney stones, urethra blockages, scientific advancements, shift from reusable to single-use hydrophilic catheters, favorable reimbursement in key markets and improving access to healthcare in emerging markets are some of the key factors driving the global continence care market. However, commoditization and entry of low-spec players are likely to hamper the market growth.

Irregular Catheters Expected to Continue Its Dominance in the Next Five Years

Intermittent catheterization is the usage of a single-use catheter to drain the bladder on a regular or semi-regular basis. It is generally used over other forms of catheterization as it offers the following advantages:

Increased Autonomy: The patient is not required to wear the catheter constantly but only at regular intervals when emptying the bladder. It simulates natural voiding and can also be used at home and workplaces

Reduced Risk of Infections: Since the time the catheter is inside the body is less in case of intermittent catheterization, it reduces the chances of urinary tract infections (UTIs) and other infections

Reduced Complications: Intermittent catheters are removed at regular intervals and hence do not get encrusted. In scenarios where it gets blocked, it can be easily removed and replaced with a new one

“Intermittent catheters segment is differentiated with users preferring products proven to lower risk of infections & having greater ease-of-use. Patients typically use 3-4 intermittent catheters a day; often for many years/lifetimes. Because of its advantages, it is likely to continue to hold a major share in the coming years." Director, Leading Continence Care Device Manufacturer, United States

Explore Premium Report on Continence Care Market @ https://meditechinsights.com/continence-care-market/

The Trend of Forward Integration – A Key Winning Strategy

The important players operating in the continence care market are progressively buying distributors/wholesalers to have deep-rooted penetration in key markets. The control of distribution channels provides prominent players more ability to increase their market shares even though the regulation requires distributors to carry competing products.

For instance,

Over the years, Convatec entered into several mergers and acquisitions [Southlake Medical USA (2019), J&R Medical USA (2018), Woodbury Holding USA (2017)] in the continence care market to establish its foothold in the market

Digital Patient Engagement – An Important Customer Acquisition Strategy

The leading players operating in the continence care market are investing in various service platforms/programs and patient support apps to retain existing customers and encourage users to upgrade to newer devices/platforms. Programs offer patients educational tools, access to nurses, advice on products & ability to capture/compare data. Key players such as Convatec & Coloplast have launched comprehensive patient support/nursing staff/apps to ensure strong patient engagement.

For instance,

The Coloplast® Care program offers:

Dedicated Care Advisor to assist patients with their product and lifestyle, education, and support

Product samples and tools to assist patients in their transition to using intermittent catheters or ostomy products

Assists patients in finding the right supplier for the product and insurance needs

Patients get monthly wellness education addressing lifestyle issues

High-tech Developments Drive the Continence Care Market

The continence care market is technology-driven and is marked by product enhancements/innovations.

For instance,

In January 2022, Otsuka Pharmaceutical Factory launched Actreen, an intermittent urological catheter. It is a single-use catheter that can be used during self-catheterization in people who have lost the urge to urinate or who usually have difficulty urinating. The surface of the catheter is coated with a hydrophilic lubricant, which can be used immediately after opening, and also contains a product with an integrated urine collection bag that can be used according to the patient's condition

In March 2021, Hollister launched the Infyna Chic™ intermittent catheter, the latest in the company's line of hydrophilic catheter products, in the US

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold

The continence care market is marked by the presence of both established and new players. Players operating in the market adopt both organic and inorganic growth strategies such as acquisitions, and new product launches to garner market share.

For instance,

In June 2022, Hollister was awarded a three-year group purchasing agreement for Urological products with Vizient, Inc., the nation’s largest member-driven health care performance improvement company. The agreement allows Vizient members increased access through negotiated pricing to the full portfolio of the Hollister Incorporated Urological products, including its VaPro™ hydrophilic catheters

The continence care market is expected to continue to grow in the coming years due to the aging population, penetration potential of intermittent catheters (ICs), improving access to healthcare in emerging markets, expanding middle-class population, better awareness & healthcare coverage, and growing cases of incontinence.

Competitive Landscape Analysis of Continence Care Market

The global continence care market is marked by the presence of players such as Coloplast, Wellspect, Bard/BD, Hollister, Convatec, Teleflex, B. Braun, UROMED, Renew Medical, and VitalCare among others.

For More Comprehensive Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

[email protected]

#Continence-Care-Market #Healthcare

0 notes